Selective and sensitive analysis of peptide hormones in clinical studies is challenging. Endogenous therapeutic peptides with a similar molecular structure, biological precursors, or inactive degradation products can interfere with the analytical method. This can lead to biased results and an erroneous biological interpretation of the study outcome. We provide an analytical solution for this challenge.
Learn more about Peptide Hormone Analysis
Schedule a conversation with
our Metabolomics Experts: croservices@joanneum.at